Uses and Abuses of Hormones and Their Analogs in Estrus Synchronization, Control of Parturition, Prophylaxis and Therapy of Infertility

Total Page:16

File Type:pdf, Size:1020Kb

Uses and Abuses of Hormones and Their Analogs in Estrus Synchronization, Control of Parturition, Prophylaxis and Therapy of Infertility Uses and Abuses of Hormones and Their Analogs in Estrus Synchronization, Control of Parturition, Prophylaxis and Therapy of Infertility Wolfgang Jochle, Dr. Vet. Med. Denville, NJ 07834, USA Hormones are an increasing important part of the Syncro-Mate-B norgestomet implant system; the veterinarian’s armatory in battling infertility, maintaining progesterone coated plastic coil for intravaginal use, fertility and controlling cycle and parturition. Therapeutic, PRID: 3, 5d, g, 6). The availability of luteolysins in prophylactic and biotechnical aspects of their use can often combination with them (estradiol esters at their no longer be separated: Cycle control methods have become insertion or prostaglandins around their removal) have tools to treat or prevent certain aspects of infertility; allowed to reduce the time progestin effects are needed methods to control parturition as a management tool are of to 6 to 9 days, by this shortened schedule avoiding the importance to terminate pathological gestations or alleviate previously well known and much discussed fertility dystocia and enable obstetrical procedures. depressing effect of these agents (1, 5b and g, 6, 7) Drug laws worldwide assure use or dispensation of these hormones by veterinarians only. Prostaglandins (PGs) themselves have become a powerful tool for cycle control (5b and g, 6). The one-or- The rowing of issues in the title of this presentation, to be discussed in this introductory review, does not reflect a two-injections cycle control method finally seems to have arrived and a dream of many seems to come ranking of their present importance. But it may well reflect its future importance. The order of discussion chosen here through and become true. follows the biological and biotechnical sequence of events in Veterinarians by now have become well aware of the problems all these new techniques create - in spite of the the life on an animal of the bovine species and the chances to be subjected to hormonal treatments. well documented fact that their correct use, in the correct setting, provides such a degree of In trying to cover such extended grounds, this reviewer synchronization that virtually all systems available has to rely heavily on previously published accounts on some allow blind A.I. at predetermined hours (3, 5b, and g). of the many issues involved (1, 2, 3, 4, 51-h) and a recently published book in which an attempt was made to cover most Prostaglandin F2a as well as all its analogs require not of this review’s subjects in some depth (6). Further on, one only cyclic corpor lutea to act on, but also the capability has to account for regional and national differences in drug of treated animals to resume cycling immediately after availability. The availability of progestins and several such an interference, if necessary twice over 10 to 12 prostaglandins in Western Europe is contrasted by the lack days. Only well managed herds and well selected of progestins and the availability of only one prostaglandin animals will respond predictably to the investment into in the U.S. Hence, aspects have to be covered that are these drugs, without creating disappointment, relevant to only part of this audience. In addition, reference frustration and often undeserved accusations against will be made to a system in which the theriogenologist of the the drug’s effectiveness (5a, g, 6,8,9,10,11,12). This is a future will build his own approaches to the hormonal shortcoming since every herd consists of unknown control of normal and abnormal reproductive functions by subpopulations of firmly, regularly cycling individuals using what is available to him locally, and in sequences and of those animals cycling on and off or entirely irregular, dosages which are not always in compliance with and of those not cycling at all. In the past, the use of recommended or governmentally approved uses - as long as progestins frequently allowed to ignore such unknowns. consumer safety (aspects of milk and meat residues) remain Progestins control regular and irregular cycles alike, assured. and often act as a “cycle starter” (2, 5b, d, g, e, 6). This A. Legitimate Uses of Hormones effect has been instrumental in part for the success 1. Estrus Cycle Synchronization. After decades of false reported when both treatment schedules are combined alarms or cumbersome solutions (daily progestrone (3, 5b, g, 12). The future may well belong to such a injections or daily feedings of such progestins as MAP, scheme, where either the 6 or 7 day use of Syncro-Mate- CAP and MAG for 12 to 18 days: 1, 5b, 6) easy B (without estradiol) or of PRID is supplemented by a applicable and removable progestins are here (the PG injection at the day of withdrawal or 24 h. earlier. NOVEMBER, 1981 65 These new schemes for cycle control are finding great attention and further detailed exploration, especially increasing use in beef and dairy heifers, also in nursing in first-calf-heifers where dystocia is a well recognized beef and lactating dairy cows as soon as regular cycles problem. The advantages such treatment has in obstetrical are established postpartum. Preparing a herd for the conditions are self-explanatory. The question how attractive successful use of such systems is probably one of the the aspect of prevention of parturition during certain hours most important tasks of veterinary supervised herd (e.g. nights) will be to the cattle industry is still open. The use health services of the future. Only herds in which the of induced parturition as a tool to synchronize parturition most sensitive index for management - the first service with milk fever prophylaxis will be reported in this session. conception rate - is up to industry standards (§0% or 3. Fertility Phophylaxis: more) will achieve the desired results from As early as 1966, the early use of cycle control synchronization (13). methods in the postpartum diary cow for the assurance 2. Control o f Parturition: of a short calving interval and the successful prevention Only in the last decade and initially not as a result of of infertility due to anestrus or acyclia was reported (18). any concerted effort to find tools for controlling Since then - first slowly, but by now with an increasing parturition, were methods developed which allow recognition of the problems’ economic importance, as manipulations of parturitions. With them, one can the papers in this section are showing - this approach of either shorten the gestation period for an early hormone use is becoming more firmly established. parturition, or assure parturition at a desirable time of Methods used in this respect in the dairy industry can be the day or the week, or at a desirable gestation length summarized as followed: (avoiding delayed gestation) (4a, b, 5c, h, 6). These Initiation of cyclic functions by GnRH or one of its methods allow us to terminate pathological gestations analogs, at about day 15 postpartum; often followed by (4a, b, 5c, 14). and prolonged gestations (15a, b). With a prostaglandin in a suitable interval (5e, 6); or initiation the principle of control of parturition established as a of cyclic functions by a progestin withdrawal or 10 to 12 desirable goal, efforts to postpone or delay parturition, days thereafter; or as soon as the presence of cyclic for short time periods, became attractive (5c, 6, 16). functions is established by milk progesterone or rectal In principle, all methods to shorten gestations use the exploration, any of the above mentioned “classical” same mechanism: luteolysis, by either endogenous cycle synchronization treatments are used (5e, 6). The prostaglandins, produced under the influence of goal is uniformly a shortening of the calving interval to exogenous hormones like certain glucocorticoids the optimum of 11.5 to 12 months (5e, 6), the discovery and/or estrogens (4a, b, 5c, 6). Prolongation of of problem cows early on and their cure and/or gestation - for a limited number of hours - can be best elimination as soon as economics dictate. This can achieved by temporarily paralyzing myometrial activity involve individual treatments or the treatments of small by a specific B2-receptor agonist (4b, 5c, h, 16). Neither groups in fixed interval to parturition. method - with the exception of really prematurely In beef cows, this involves the use of cycle delivered calves - adversely affects the calfs viability. synchronization techniques as soon as cyclic functions Induction of parturition, if it occurs before term, results are restored (or are expected to be restored in the in a high level of placental retainment - a complication majority of the population), often coinciding with the of little concern to beef breeders, but of much concern to beginning of the breeding season. (5e, 6). the dairy producer. This healthy retained placenta - 4. Infertility Therapy: resulting from a desynchronization of the normally well Specific neurohormonal or pharmacological aspects synchronized departure of fetus and placenta - needs of hormones (and their analogs) have become time to mature, i.e. to go to its own term. Systemic - not indispensable therapeutic tools for the veterinarian: local - antibiosis helps to achieve this goal. Of the Resting or insufficiently working ovaries are treatments to prepare the placenta for a simultaneous stimulated directly by releaser hormones or early delivery of fetus and placenta, weeklong gonadotropins, or indirectly via positive feedbacks by application of low doses of certain long acting the shorterm use of sex steroids (natural estrogens; glucocorticoids is the most successful (17). This estrogen-androgen-combinations), or negative treatment, followed by a boost with a short acting feedback (the use of progestins as an “artifical corpus dexamethasone ester assures parturition at the wanted luteum”) (6). time, a viable calf and shedding of the placenta (17). Silently cycling animals are challenged by similar Postponement of parturition by a highly specific B22 methods or are “exposed” by luteolytic prostaglandins; memetic agent (Planipart B2 mimetic r ) features dominantly ovarian cysts are treated, preferably after a milk in this session.
Recommended publications
  • Efficiency of Different Methods of Estrus Synchronization Followed by Fixed Time Artificial Insemination in Persian Downy Does
    DOI: 10.21451/1984-3143-AR825 Anim. Reprod., v.14, n.2, p.413-417, Apr./Jun. 2017 Efficiency of different methods of estrus synchronization followed by fixed time artificial insemination in Persian downy does Majid Hashemi1, 2, 3, Mazaher Safdarian2 1Razi Vaccine and Serum Research Institute, Shiraz Branch, Agricultural Research, Education and Extension Organization (AREEO), Shiraz, Iran. 2Animal Science Research Department, Fars Agricultural and Natural Resource Research and Education Center, Agricultural Research, Education and Extension Organization (AREEO), Shiraz, Iran. Abstract estrus synchronization can play an important role for managing production system, allowing the density of For evaluating different methods of long term estrous mating and kidding and production of meat and milk synchronization followed by fixed time artificial during specific times of the year for strategic marketing insemination and to select the most efficient method, and other purposes (Baldassarre and Karatzas, 2004, during the breeding season 160 Persian downy does Zhao et al., 2010). In small ruminants, hormonal estrus were equally allocated to groups (n = 20/group). Estrus synchronization is achieved either by reducing the was synchronized using controlled internal drug release length of the luteal phase of the estrous cycle with devices alone (CIDR) or with equine chorionic prostaglandin F2α or by extending the cycle artificially gonadotropin (CIDR-eCG), intravaginal sponge with exogenous progesterone or more potent impregnated with 45 mg fluorgestone acetate alone progestagens (Hashemi et al., 2006, Abecia et al., (Sponge) or with eCG (Sponge-eCG), subcutaneous 2012). Progestogen administration is common and has auricular implant of 2 mg norgestomet alone (Implant) been used with or without accompanying treatments or with eCG (Implant-eCG) or two intramuscular such as gonadatropins or prostaglandin analogs.
    [Show full text]
  • Reproductive Physiology of the Beef Heifer
    Reproductive Physiology of the Beef Heifer Bob L. Larson, DVM, PhD, ACT Hormones Controlling the Estrous Cycle Brain Anterior Hypothalamus Pituitary GnRH n ne e o g FSH r o e rr t s st LH E ge o r P Corpus Uterus Luteum Gn RH Preovulatory Follicle Hypothalamus - Releases small peptides of which GnRH is of direct importance Brain GnRH causes Anterior Hypothalamus pituitary release Pituitary GnRH of FSH and LH ® ® Cystorelin , Factrel , and Fertagyl® are commercially available Ant. Pituitary - FSH stimulates the maturation of 2o follicles LH stimulates maturation of 3o follicles and stimulates estrogen production LH stimulates CL Anterior Pituitary GnRH production of P4 FSH PMSG (eCG) gives LH primarily FSH activity Corpus Luteum hCG gives primarily LH Preovulatory Follicle activity ActionAction ofof GnRHGnRH • Causes release of Luteinizing Hormone (LH) • Ovulation or luteinization • Initiates new follicular wave • CL formation Corpus Luteum - Progesterone prepares the uterus for the egg (d5) P4 acts on the brain to override estrogen to prevent estrus behavior Brain Melengestrol acetate (MGA) Anterior Hypothalamus is synthetic progestogen and Pituitary GnRH natural progesterone is found ne ® o in CIDR insert r e t LH s ge o r P Higher levels of P4 are Corpus Uterus Luteum needed to prevent ovulation than estrus ActionAction ofof ProgesteroneProgesterone • Secreted by CL • Suppress estrus and ovulation • Pregnancy maintenance • “Jump starts” anestrus cows Corpus Luteum Brain Anterior Hypothalamus We control the Pituitary GnRH estrous cycle
    [Show full text]
  • An End-To-End Workflow for Quantitative Screening of Multiclass, Multiresidue Veterinary Drugs in Meat Using the Agilent 6470 Triple Quadrupole LC/MS
    Application Note Food Testing & Agriculture An End-To-End Workflow for Quantitative Screening of Multiclass, Multiresidue Veterinary Drugs in Meat Using the Agilent 6470 Triple Quadrupole LC/MS Authors Abstract Siji Joseph, Aimei Zou, Chee A comprehensive LC/MS/MS workflow was developed for targeted screening or Sian Gan, Limian Zhao, and quantitation of 210 veterinary drug residues in animal muscle prepared for human Patrick Batoon consumption, with the intention to accelerate and simplify routine laboratory testing. Agilent Technologies, Inc. The workflow ranged from sample preparation through chromatographic separation, MS detection, data processing and analysis, and report generation. The workflow performance was evaluated using three muscle matrices—chicken, pork, and beef— and was assessed on two different Agilent triple quadrupole LC/MS models (an Agilent 6470 and a 6495C triple quadrupole LC/MS). A simple sample preparation protocol using Agilent Captiva EMR—Lipid cartridges provided efficient extraction and matrix cleanup. A single chromatographic method using Agilent InfinityLab Poroshell 120 EC-C18 columns with a 13-minute method delivered acceptable separation and retention time distribution across the elution window for reliable triple quadrupole detection and data analysis. Workflow performance was evaluated based on evaluation of limit of detection (LOD), limit of quantitation (LOQ), calibration curve linearity, accuracy, precision, and recovery, using matrix-matched spike samples for a range from 0.1 to 100 μg/L. Calibration curves were plotted from LOQ to 100 μg/L, where all analytes demonstrated linearity R2 >0.99. Instrument method accuracy values were within 73 to 113%. Target analytes response and retention time %RSD values were ≤19% and ≤0.28% respectively.
    [Show full text]
  • Response of Prepuberal Heifers to Norgestomet And/Or Follicular Fluid and the Induction of Estrus in Ovariectomized Cows with Syncro-Mate B
    THE RESPONSE OF PREPUBERAL HEIFERS TO NORGESTOMET AND/OR FOLLICULAR FLUID AND THE INDUCTION OF ESTRUS IN OVARIECTOMIZED COWS WITH SYNCRO-MATE B by WILLIAM JOSEPH MCGUIRE B.S., Kansas State University, 1983 A THESIS submitted in partial fulfillment of the requirements for the degree MASTER OF SCIENCE ANIMAL SCIENCES KANSAS STATE UNIVERSITY Manhattan, Kansas 1989 Approved by: ACKNOWLEDGEMENTS The author wishes to express his appreciation to Dr. Guy H. Kiracofe, Professor of Animal Science, for his tireless effort, enthusiasm and guidance during the pursuit of my graduate degree. Special thanks is extended to Dr. Kiracofe for his friendship and confidence. The author also wishes to thank Dr. Jeff Stevenson, Professor of Animal Science, and Dr. Bob Schalles, Professor of Animal Science, for their help as members of his committee. A debt of gratitude is extended to fellow graduate student Jeanne Wright, for all of her help, assistance and mostly her friendship while I was just getting started in my graduate program. Special thanks are also extended to fellow graduate students Steve Viker, Bob Larson, Mike Mee, Tim Delcurto, Tim Coppinger, Robert Stewart, and Randy Perry for their help and assistance throughout all of the experiments. To Tammy Delcurto go many thanks for her assistance in analyzing the many blood samples, and for her tireless sense of humor. A debt is owed to Roy Gehrt, whose horse-sense and hard work not only helped accomplish the many experiments, but made them a more enjoyable experience. The author is also grateful to the Department of Animal Science and Dr. G. H.
    [Show full text]
  • Jim Lauderdale.Pdf
    Proceedings, Applied Reproductive Strategies in Beef Cattle January 28-29, 2010; San Antonio, TX WHERE WE HAVE BEEN AND WHERE WE ARE TODAY: HISTORY OF THE DEVELOPMENT OF PROTOCOLS FOR BREEDING MANAGEMENT OF CATTLE THROUGH SYNCHRONIZATION OF ESTRUS AND OVULATION J. W. Lauderdale Lauderdale Enterprises, Inc. Augusta, MI 49012 Introduction Reproductive efficiency is one of the most important factors for successful cow-calf enterprises. Certainly, in the absence or reproduction, there is no cow-calf enterprise. During the 1950s frozen bovine semen was developed and AI with progeny tested bulls became recognized as effective to make more rapid genetic progress for milk yield and beef production. During the interval 1950s through 1960s, a major detriment to AI in beef cattle was the requirement for daily estrus detection and AI over 60 to 90 days or more. Therefore, with the availability of artificial insemination, further control of estrus and breeding management was of greater interest and value, especially to the beef producer. Additional publications, not addressed herein, provide reviews of the development of cattle estrus and breeding management (Wiltbank, 1970; Wiltbank, 1974; Odde, 1990; Mapletoft et al., 2003; Patterson et al., 2003a; Kojima, 2003; Kesler, 2003; Patterson et al., 2003b; Chenault et al., 2003; Stevenson et al., 2003; Lamb et al., 2003). Early research on the estrous cycle Research to understand estrus and estrous cycles was initiated in the United States by Dr. Fred F. McKenzie and his graduate students at the University of Missouri in the 1920s using sheep. McKenzie (1983) began leading an animal research laboratory at the University of Missouri in 1923.
    [Show full text]
  • Residual Levels on Medroxyprogesterone Acetate
    Braz. J. vet. Res. an ini. 5c/., São Paulo, v.34, n. 3. p. 163-166, 1997. CORRESPONDENCE TO: Residual levels on medroxyprogesterone acetate- Laura Simonetti Faculdad Ingenieria y Ciencias impregnated sponges after estrus synchronization Agrarias Universidad Nacional Lomas de Zamora treatment and their relationship with fertility in cyclic Casilla de Correo 95 1832 - Lomas de Zamora ■ goats Argentina e-mail: simoneti & siscor. txbnat. edu.ar Níveis residuais em esponjas impregnadas com acetato de 1 - Faculdad Ingeneria y Ciencias Agrarias Universidad Nacional Lomas de medroxiprogesterona, após tratamento de sincronização do estro Zamora, Lomas de Zamora, Argentina e sua relação com a fertilidade nas cabras em período reprodutivo Juan Carlos GARDON1; Laura SIMONETTI1 SUMMARY A pool polyurethane sponges impregnated with medroxyprogesterone acetate (MAP) was prepared. Real level of progestagen on sponges was checked prior to sponges insertion. 13 cyclic goats were intravaginally treated with MAP-impregnated pessaries for the synchronization of estrus. After 14 days treatment, sponges were removed. 48 hours post-withdrawal, goats which exhibited estrus were artificially inseminated. Residual levels of MAP on removed sponges were measured by spectrophotometry at 241 nM. and examined in relation to their fertility. The real dose of MAP was in average 62 mg + 2 mg. High levels (x = 32,46 mg + 9,84 mg) of residual MAP were found on sponges following treatment. The percentage of estrus synchronization was 92,31% and the pregnancy rate was 69,23%. Pregnant goats had significantly higher (p< 0,01) residual amounts of hormone (x = 35,56 mg + 6,06mg) remaining on sponges than non-pregnant goats (x = 20,00 mg ± 10,58 mg).
    [Show full text]
  • Journal of the Hellenic Veterinary Medical Society
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by National Documentation Centre - EKT journals Journal of the Hellenic Veterinary Medical Society Vol. 69, 2018 Different estrus induction protocols and fixed time artificial insemination during the anoestrous period in non-lactating Kivircik ewes DOGAN I. Uludag University, Veterinary Faculty, Department of Reproduction and Artificial Insemination NUR Z. Uludag University, Veterinary Faculty, Department of Reproduction and Artificial Insemination KILINC B. Uludag University, Institute of Health Science https://doi.org/10.12681/jhvms.16429 Copyright © 2018 I DOGAN, Z NUR, B KILINC To cite this article: DOGAN, I., NUR, Z., & KILINC, B. (2018). Different estrus induction protocols and fixed time artificial insemination during the anoestrous period in non-lactating Kivircik ewes. Journal of the Hellenic Veterinary Medical Society, 69(1), 801-808. doi:https://doi.org/10.12681/jhvms.16429 http://epublishing.ekt.gr | e-Publisher: EKT | Downloaded at 21/04/2020 03:53:54 | Research article J HELLENIC VET MED SOC 2018, 69(1): 801-808 ΠΕΚΕ 2018, 69(1): 801-808 Ερευνητικό άρθρο Different estrus induction protocols and fixed time artificial insemination during the anoestrous period in non-lactating Kivircik ewes Dogan I. 1*, Nur Z.1, Kilinc B.2 1 Uludag University, Veterinary Faculty, Department of Reproduction and Artificial Insemination 16059 Gorukle/Bursa TURKEY 2 Uludag University, Institute of Health Science 16059 Gorukle/Bursa TURKEY ABSTRACT. The efficiency of medroxyprogesterone acetate (MAP) sponges or norgestomet ear implants (half or entire) for synchronizing and inducing the estrous cycle in non-lactating Kivircik ewes was investigated during the nat- ural non-breeding period.
    [Show full text]
  • Customs Tariff - Schedule
    CUSTOMS TARIFF - SCHEDULE 99 - i Chapter 99 SPECIAL CLASSIFICATION PROVISIONS - COMMERCIAL Notes. 1. The provisions of this Chapter are not subject to the rule of specificity in General Interpretative Rule 3 (a). 2. Goods which may be classified under the provisions of Chapter 99, if also eligible for classification under the provisions of Chapter 98, shall be classified in Chapter 98. 3. Goods may be classified under a tariff item in this Chapter and be entitled to the Most-Favoured-Nation Tariff or a preferential tariff rate of customs duty under this Chapter that applies to those goods according to the tariff treatment applicable to their country of origin only after classification under a tariff item in Chapters 1 to 97 has been determined and the conditions of any Chapter 99 provision and any applicable regulations or orders in relation thereto have been met. 4. The words and expressions used in this Chapter have the same meaning as in Chapters 1 to 97. Issued January 1, 2019 99 - 1 CUSTOMS TARIFF - SCHEDULE Tariff Unit of MFN Applicable SS Description of Goods Item Meas. Tariff Preferential Tariffs 9901.00.00 Articles and materials for use in the manufacture or repair of the Free CCCT, LDCT, GPT, UST, following to be employed in commercial fishing or the commercial MT, MUST, CIAT, CT, harvesting of marine plants: CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, Artificial bait; KRT, CEUT, UAT, CPTPT: Free Carapace measures; Cordage, fishing lines (including marlines), rope and twine, of a circumference not exceeding 38 mm; Devices for keeping nets open; Fish hooks; Fishing nets and netting; Jiggers; Line floats; Lobster traps; Lures; Marker buoys of any material excluding wood; Net floats; Scallop drag nets; Spat collectors and collector holders; Swivels.
    [Show full text]
  • Steroidal Estrogens
    FINAL Report on Carcinogens Background Document for Steroidal Estrogens December 13 - 14, 2000 Meeting of the NTP Board of Scientific Counselors Report on Carcinogens Subcommittee Prepared for the: U.S. Department of Health and Human Services Public Health Service National Toxicology Program Research Triangle Park, NC 27709 Prepared by: Technology Planning and Management Corporation Canterbury Hall, Suite 310 4815 Emperor Blvd Durham, NC 27703 Contract Number N01-ES-85421 Dec. 2000 RoC Background Document for Steroidal Estrogens Do not quote or cite Criteria for Listing Agents, Substances or Mixtures in the Report on Carcinogens U.S. Department of Health and Human Services National Toxicology Program Known to be Human Carcinogens: There is sufficient evidence of carcinogenicity from studies in humans, which indicates a causal relationship between exposure to the agent, substance or mixture and human cancer. Reasonably Anticipated to be Human Carcinogens: There is limited evidence of carcinogenicity from studies in humans which indicates that causal interpretation is credible but that alternative explanations such as chance, bias or confounding factors could not adequately be excluded; or There is sufficient evidence of carcinogenicity from studies in experimental animals which indicates there is an increased incidence of malignant and/or a combination of malignant and benign tumors: (1) in multiple species, or at multiple tissue sites, or (2) by multiple routes of exposure, or (3) to an unusual degree with regard to incidence, site or type of tumor or age at onset; or There is less than sufficient evidence of carcinogenicity in humans or laboratory animals, however; the agent, substance or mixture belongs to a well defined, structurally-related class of substances whose members are listed in a previous Report on Carcinogens as either a known to be human carcinogen, or reasonably anticipated to be human carcinogen or there is convincing relevant information that the agent acts through mechanisms indicating it would likely cause cancer in humans.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr
    US008158152B2 (12) United States Patent (10) Patent No.: US 8,158,152 B2 Palepu (45) Date of Patent: Apr. 17, 2012 (54) LYOPHILIZATION PROCESS AND 6,884,422 B1 4/2005 Liu et al. PRODUCTS OBTANED THEREBY 6,900, 184 B2 5/2005 Cohen et al. 2002fOO 10357 A1 1/2002 Stogniew etal. 2002/009 1270 A1 7, 2002 Wu et al. (75) Inventor: Nageswara R. Palepu. Mill Creek, WA 2002/0143038 A1 10/2002 Bandyopadhyay et al. (US) 2002fO155097 A1 10, 2002 Te 2003, OO68416 A1 4/2003 Burgess et al. 2003/0077321 A1 4/2003 Kiel et al. (73) Assignee: SciDose LLC, Amherst, MA (US) 2003, OO82236 A1 5/2003 Mathiowitz et al. 2003/0096378 A1 5/2003 Qiu et al. (*) Notice: Subject to any disclaimer, the term of this 2003/OO96797 A1 5/2003 Stogniew et al. patent is extended or adjusted under 35 2003.01.1331.6 A1 6/2003 Kaisheva et al. U.S.C. 154(b) by 1560 days. 2003. O191157 A1 10, 2003 Doen 2003/0202978 A1 10, 2003 Maa et al. 2003/0211042 A1 11/2003 Evans (21) Appl. No.: 11/282,507 2003/0229027 A1 12/2003 Eissens et al. 2004.0005351 A1 1/2004 Kwon (22) Filed: Nov. 18, 2005 2004/0042971 A1 3/2004 Truong-Le et al. 2004/0042972 A1 3/2004 Truong-Le et al. (65) Prior Publication Data 2004.0043042 A1 3/2004 Johnson et al. 2004/OO57927 A1 3/2004 Warne et al. US 2007/O116729 A1 May 24, 2007 2004, OO63792 A1 4/2004 Khera et al.
    [Show full text]
  • Residues of Medroxyprogesterone Acetate Detected in Sows at A
    This article was downloaded by: [Cirad-Dist Bib Lavalette] On: 22 November 2013, At: 10:04 Publisher: Taylor & Francis Informa Ltd Registered in England and Wales Registered Number: 1072954 Registered office: Mortimer House, 37-41 Mortimer Street, London W1T 3JH, UK Food Additives & Contaminants: Part A Publication details, including instructions for authors and subscription information: http://www.tandfonline.com/loi/tfac20 Residues of medroxyprogesterone acetate detected in sows at a slaughterhouse, Madagascar Vincent Porphyrea, Michel Rakotoharinomeb, Tantely Randriamparanyc, Damien Pognona, Stéphanie Prévostd & Bruno Le Bizecd a Centre de Coopération Internationale en Recherche Agronomique pour le Développement – CIRAD, Réunion, France b Direction of Veterinary Services, Ministry of Livestock Production, Antananarivo, Madagascar c National Laboratory of Veterinary Diagnostic, Antananarivo, Madagascar d Laboratoire d’Etude des Résidus et Contaminants dans les Aliments (LABERCA), Ecole Nationale Vétérinaire, Agroalimentaire et de l’Alimentation Nantes Atlantique (ONIRIS), Nantes, France Accepted author version posted online: 24 Sep 2013.Published online: 20 Nov 2013. To cite this article: Vincent Porphyre, Michel Rakotoharinome, Tantely Randriamparany, Damien Pognon, Stéphanie Prévost & Bruno Le Bizec , Food Additives & Contaminants: Part A (2013): Residues of medroxyprogesterone acetate detected in sows at a slaughterhouse, Madagascar, Food Additives & Contaminants: Part A, DOI: 10.1080/19440049.2013.848293 To link to this article: http://dx.doi.org/10.1080/19440049.2013.848293 PLEASE SCROLL DOWN FOR ARTICLE Taylor & Francis makes every effort to ensure the accuracy of all the information (the “Content”) contained in the publications on our platform. However, Taylor & Francis, our agents, and our licensors make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content.
    [Show full text]